Febuxostat Ethyl Ester CAS 160844-75-7 Puritas >99.0% (HPLC) Febuxostat Intermedia Factory
Ruifu Chemical Supple Febuxostat intermedia:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS, 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161797-99-5
Nomen chemicum | Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylatus |
Synonyma | Febuxostat Ethyl Ester;Febuxostat Ethyl Ester Impurity;Febuxostat immunditia 15;Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylata;2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylic Acidum Ethyl Ester |
CAS Number | 160844-75-7 |
CATTUS Number | RF-PI1857 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C18H20N2O3S |
M. Pondus | 344.43 |
Liquescens punctum | 174.0 ad 178.0℃ |
Density | 1.22 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba vel Off-White pulveris |
Lepidium sativum | HPC, NMR;LC-MS |
Substantiae cognatae | |
Individual Impurity | <0.50% |
Totalis immunditias | <1.00% |
Damnum in Siccatio | <0.50% |
Residere in Ignition | <0.20% |
Metalla gravis | <10ppm |
Puritas / Analysis Methodus | >99.0% (HPLC) |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Febuxostat (CAS: 144060-53-7); |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylatus (CAS: 160844-75-7) est medium seu immunditia febuxostatae (CAS: 144060-53-7), oxydatum xanthine/ xanthine dehydrogenase inhibitor.Usus est ad curationem hyperuricemiae et podagrae chronicae.40-120 mg/diei Febuxostat efficax probatum est in gradibus seri uratis deducendis, cum hyperuricemia aegrotis podagra administravit.